RxDoctor Payments Data

Kimberly Tran, MD

Retina Specialist · Phoenix, AZNPI 1215279104

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 24.6% of the total. That places this record below the midpoint for retina specialist clinicians in AZ, where the typical reported total is $12,789.

$2,466in general payments, 2019–2025

Across 53 payments — averaging $46.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$606
  • Novartis$364
  • Alimera Sciences, Inc.$293
  • Genentech USA, Inc.$251
  • Astellas Pharma US Inc$215
  • Alcon$163
  • plus $574 from 8 others

What the payments were for

  • Food & beverage$2,466100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,466 in reported general payments places this provider in the 15th percentile of 30 retina specialist providers in Arizona.

See all retina specialist providers in Arizona

Medicare billing

Part B allowed, 2024
$231,723
Medicare patients
474
Services billed
2,718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketorolac Tromethamine38$2,723
Prednisolone Acetate48$2,507
Difluprednate17$1,892
Latanoprost114$1,836
ValacyclovirValacyclovir Hcl25$818
Brimonidine Tartrate36$736
Timolol Maleate86$609
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat39$539
Dorzolamide Hcl24$400
ErythromycinErythromycin Base29$297
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha13$146
Ofloxacin14$124

Paid to pharmacies, not to this prescriber.

Other retina specialist in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →